160 related articles for article (PubMed ID: 35244991)
21. The relative impact and future burden of prostate cancer in the United States.
Chan JM; Jou RM; Carroll PR
J Urol; 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. PubMed ID: 15535436
[TBL] [Abstract][Full Text] [Related]
22. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
Malvezzi M; Bertuccio P; Rosso T; Rota M; Levi F; La Vecchia C; Negri E
Ann Oncol; 2015 Apr; 26(4):779-786. PubMed ID: 25623049
[TBL] [Abstract][Full Text] [Related]
23. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.
Bray F; Jemal A; Grey N; Ferlay J; Forman D
Lancet Oncol; 2012 Aug; 13(8):790-801. PubMed ID: 22658655
[TBL] [Abstract][Full Text] [Related]
24. Estimates and projections of value of life lost from cancer deaths in the United States.
Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
[TBL] [Abstract][Full Text] [Related]
25. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010.
Jung KW; Won YJ; Kong HJ; Oh CM; Seo HG; Lee JS
Cancer Res Treat; 2013 Mar; 45(1):1-14. PubMed ID: 23613665
[TBL] [Abstract][Full Text] [Related]
26. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
27. Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.
Park S; Jee SH; Shin HR; Park EH; Shin A; Jung KW; Hwang SS; Cha ES; Yun YH; Park SK; Boniol M; Boffetta P
BMC Cancer; 2014 Jun; 14():406. PubMed ID: 24902960
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Cancer Incidence and Mortality in Korea, 2018.
Jung KW; Won YJ; Kong HJ; Lee ES
Cancer Res Treat; 2018 Apr; 50(2):317-323. PubMed ID: 29566480
[TBL] [Abstract][Full Text] [Related]
29. Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older.
Hong Y; Lee S; Moon S; Sung S; Lim W; Kim K; An S; Choi J; Ko KP; Kim I; Lee JE; Park SK
J Prev Med Public Health; 2022 Nov; 55(6):529-538. PubMed ID: 36475318
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer mortality in New Zealand: the past and projections for the future.
Cohen RJ; Robinson E; McRae CU
Aust N Z J Surg; 1997 Nov; 67(11):781-4. PubMed ID: 9396994
[TBL] [Abstract][Full Text] [Related]
31. Nationwide cancer incidence in Korea, 2003-2005.
Won YJ; Sung J; Jung KW; Kong HJ; Park S; Shin HR; Park EC; Ahn YO; Hwang IK; Lee DH; Choi JS; Kim WC; Lee TY; Yoo CI; Bae JM; Kim ON; Chung W; Kong IS; Lee DH; Lee JS
Cancer Res Treat; 2009 Sep; 41(3):122-31. PubMed ID: 19809561
[TBL] [Abstract][Full Text] [Related]
32. Incidence of prostate cancer and net survival by grade in a geriatric population: A population-based study in a French administrative entity from 1991 to 2013.
Bellier A; Colonna M; Delafosse P; Seigneurin A
Cancer Epidemiol; 2018 Oct; 56():60-66. PubMed ID: 30048940
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer incidence and mortality in Navarre (Spain).
Etxeberria J; Guevara M; Moreno-Iribas C; Burgui R; Delfrade I; Floristán Y; Montesino M; Ardanaz E
An Sist Sanit Navar; 2018 Apr; 41(1):9-15. PubMed ID: 29358783
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Cancer Incidence and Mortality in Korea, 2020.
Jung KW; Won YJ; Hong S; Kong HJ; Lee ES
Cancer Res Treat; 2020 Apr; 52(2):351-358. PubMed ID: 32178488
[TBL] [Abstract][Full Text] [Related]
35. Metachronous malignancies in men with previous prostate cancer in Umbria, Italy, 1994-2003.
Cassetti T; Stracci F; Minelli L; Scheibel M; Sapia IE; La Rosa F
Tumori; 2008; 94(1):7-10. PubMed ID: 18468327
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.
Pina F; Castro C; Ferro A; Bento MJ; Lunet N
Eur J Cancer Prev; 2017 Sep; 26(5):404-410. PubMed ID: 27483413
[TBL] [Abstract][Full Text] [Related]
37. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
39. Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model.
Ruan Y; Poirier A; Yong J; Garner R; Sun Z; Than J; Brenner DR
Prev Med; 2023 Mar; 168():107425. PubMed ID: 36681276
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer in American Indians, New Mexico, 1969 to 1994.
Gilliland FD; Key CR
J Urol; 1998 Mar; 159(3):893-7; discussion 897-8. PubMed ID: 9474177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
